IRWD analyst estimates
Ironwood (IRWD) analyst ratings, the average price target and its range, and every firm's latest call.
IRWD analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Feb 26, 2026 | Jefferies | Ironwood Pharmaceuticals (IRWD) PT Raised to $3.70 at Jefferies | $3.70 |
| Jan 5, 2026 | Craig-Hallum | Craig-Hallum upgrades Ironwood to Buy following 2026 guidance | $5.70 |
| Jan 4, 2026 | Wells Fargo | Ironwood price target raised to $5 from $3 at Wells Fargo | $5.00 |
| Nov 26, 2025 | Craig-Hallum | Ironwood price target raised to $3.80 from $1.70 at Craig-Hallum | $3.80 |
| Apr 14, 2025 | Leerink Partners | Ironwood price target lowered to $1 from $3 at Leerink | $1.00 |
| Jan 31, 2025 | Wells Fargo | Ironwood price target lowered to $7 from $12 at Wells Fargo | $7.00 |
| Sep 9, 2024 | Leerink Partners | Ironwood initiated with a Market Perform at Leerink | $5.00 |
| Aug 9, 2024 | Wells Fargo | Ironwood price target lowered to $12 from $14 at Wells Fargo | $12.00 |
| May 22, 2024 | Wells Fargo | Wells Fargo Reiterates Overweight Rating on Ironwood Pharmaceuticals (IRWD) | $14.00 |
| May 22, 2024 | Piper Sandler | Piper Sandler Reiterates Overweight Rating on Ironwood Pharmaceuticals (IRWD) | $18.00 |
| Apr 22, 2022 | Piper Sandler | Ironwood Pharmaceuticals (IRWD) Stock: Why The Price Increased 3.4% Today | $16.00 |
- 2 firms rate IRWD: 1 buy, 1 hold, 0 sell.
Updated 2026-11-06 07:48 UTC